S-1 · primary offering
Proposed maximum
Shares registered
- Filed
- Effective
Sector: Electromedical & Electrotherapeutic ApparatusIndustry: BiotechnologyCountry: USExchange: NYSE
DilutionScan read 54 of Neuraxis, INC's SEC filings and found 5 warrant series, 2 convertibles, 1 ATM program, 2 shelf registrations, 1 S-1 registration and 3 completed offerings on file for NRXS. The latest dilution event on file is a registration statement on Aug 3, 2026. Analysis updated Nov 1, 2026.
Raise routes on file: active ATM + effective shelf · latest dilution event 92 days ago
The dominant contractual driver and its mechanism, then each further driver ranked.
Aug 3, 2026 · Registration
Every warrant, convertible, ATM and shelf, cited to the filing
A free account reads 3 tickers a day in full
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
Shares outstanding, potential dilution and cash over time
Proposed maximum
Shares registered
Shares Underlying
Exercise Price
Shares Underlying
Exercise Price
Shares Underlying
Exercise Price
Shares Underlying
Exercise Price
Shares Underlying
Exercise Price
Principal
Conversion Price
Principal
Conversion Price
Issued 2025
Total capacity
Sold to date
Issued 2024
Total capacity
Remaining
Issued 2026
Total capacity
Remaining
Issued 2025
Gross proceeds
Price per share
Gross proceeds
Price per share
Gross proceeds
Price per share
Exercise prices, conversion terms, shelf headroom and the filing sentence behind every number.
$59/mo with 7 days free, or $49/mo billed yearly ($588/yr)
DilutionScan ProEvery instrument in full · $59/mo
Covered companies in Biotechnology. All tickers A to Z